The Discounted Cash Flow (DCF) valuation of Arbutus Biopharma Corp (ABUS) is (3.86) USD. With the latest stock price at 3.64 USD, the upside of Arbutus Biopharma Corp based on DCF is -206.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.7% - 7.4% | 6.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (14.33) - (2.24) | (3.86) |
| Upside | -493.6% - -161.4% | -206.1% |